AB Large Cap Value Fund Class A
ABVAX
NASDAQ
| Weiss Ratings | ABVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Fair | |||
| Reward Grade | C+ | |||
| Risk Index | Good | |||
| Risk Grade | B | |||
| Company Info | ABVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Provider | AllianceBernstein | |||
| Manager/Tenure (Years) | Cem Inal (9) | |||
| Website | -- | |||
| Fund Information | ABVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Fund Name | AB Large Cap Value Fund Class A | |||
| Category | Large Value | |||
| Sub-Category | US Equity Large Cap Value | |||
| Prospectus Objective | Growth | |||
| Inception Date | Mar 29, 2001 | |||
| Open/Closed To New Investors | Open | |||
| Minimum Initial Investment | 2,500.00 | |||
| Minimum Subsequent Investment | 50.00 | |||
| Front End Fee | 0.04 | |||
| Back End Fee | -- | |||
| Dividends and Shares | ABVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield | 0.93% | |||
| Dividend | ABVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield (Forward) | 2.11% | |||
| Asset Allocation | ABVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash | 0.73% | |||
| Stock | 99.27% | |||
| U.S. Stock | 97.60% | |||
| Non-U.S. Stock | 1.67% | |||
| Bond | 0.00% | |||
| U.S. Bond | 0.00% | |||
| Non-U.S. Bond | 0.00% | |||
| Preferred | 0.00% | |||
| Convertible | 0.00% | |||
| Other Net | 0.00% | |||
| Price History | ABVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -0.27% | |||
| 30-Day Total Return | 3.96% | |||
| 60-Day Total Return | 2.11% | |||
| 90-Day Total Return | 8.45% | |||
| Year to Date Total Return | 8.32% | |||
| 1-Year Total Return | 10.74% | |||
| 2-Year Total Return | 30.63% | |||
| 3-Year Total Return | 49.37% | |||
| 5-Year Total Return | 98.95% | |||
| Price | ABVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Closing Price | -- | |||
| 1-Month Low Price | -- | |||
| 1-Month High Price | -- | |||
| 52-Week Low Price | -- | |||
| 52-Week Low Price (Date) | -- | |||
| 52-Week High Price | -- | |||
| 52-Week High Price (Date) | -- | |||
| NAV | ABVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Nav | $18.35 | |||
| 1-Month Low NAV | $17.74 | |||
| 1-Month High NAV | $18.46 | |||
| 52-Week Low NAV | $15.17 | |||
| 52-Week Low NAV (Date) | Apr 08, 2025 | |||
| 52-Week High NAV | $20.58 | |||
| 52-Week High Price (Date) | Nov 29, 2024 | |||
| Beta / Standard Deviation | ABVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.02 | |||
| Standard Deviation | 16.72 | |||
| Balance Sheet | ABVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Total Assets | 433.09M | |||
| Operating Ratios | ABVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Expense Ratio | 0.89% | |||
| Turnover Ratio | 53.00% | |||
| Performance | ABVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Last Bull Market Total Return | 17.86% | |||
| Last Bear Market Total Return | -11.39% | |||